EP300 and colorectal carcinoma: In CRC, YY1 was detected to cooperate with HDAC2 to suppress miR‐500a‐5p promoter transcription, while p300 moderates the effect by binding to the upstream YY1‐binding sites of miR‐500a‐5p promoter in CRC cells.58